Exosome RNA Exosome RNA Research & Industry News
CareFirst BlueCross BlueShield (CareFirst), today announced that it has reached a positive coverage decision for the ExoDx® Prostate(IntelliScore) or EPI test – meaning that the test will be covered for CareFirst members beginning in 2018. This coverage decision is based ...
Read More »CareFirst BlueCross BlueShield announces coverage of new exosome liquid biopsy tests for prostate cancer
